Blog

Serious Safety Concerns Associated with Drugs Like Ozempic

In a recent report published in Cureus, researchers from Miller Scientific—a boutique research organization—identified over 287,000 adverse events associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs). These drugs, such as Ozempic, Rybelsus, Byetta, and Victoza, are prescribed to treat type 2 diabetes. The events included death, life-threatening events, prolonged hospitalizations, and persistent or significant disability. If…

read more